SEC Form 4 · accession 0001104659-15-023152
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jones W. Bryan
Officer — VP of Business Development
Period of report
Mar 24, 2015
Accepted (ET)
Mar 26, 2015 · 5:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 24, 2015 | M | 1,875 | $3.36 | A | 69,855 | D | |
| Common Stock | Mar 24, 2015 | M | 25 | $2.56 | A | 69,880 | D | |
| Common Stock | Mar 24, 2015 | S | 1,900 | $12.00 | D | 67,980 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $3.36 | Mar 24, 2015 | M | 1,875 | D | — | Feb 10, 2020 | Common Stock | 1,875 | 625 | D |
| Employee Stock Option (Right to Buy)F3 | $2.56 | Mar 24, 2015 | M | 25 | D | — | Nov 2, 2020 | Common Stock | 25 | 37,475 | D |
Explanation of responses
- F1Transaction made pursuant to a Rule 10b5-1 trading plan adopted on April 21, 2014.
- F2The option vested in four equal annual installments beginning on February 10, 2011.
- F3The option vested in four equal annual installments beginning on November 2, 2011.